Life expectancy following PE is influenced ... Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare complication of PE that can cause chronic shortness of breath. CTEPH is a form ...

Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy ...

A recent publication in the International Journal of Cardiology, Pulmonary ... effective and life-changing treatments for patients with complex conditions like pulmonary hypertension.

The new drug sotatercept stops the remodelling of the pulmonary vessels and even helps patients with advanced pulmonary arterial hypertension (PAH) who have not yet been treated.

Pulmonary arterial hypertension (PAH ... heart failure and reduced life expectancy. The cause is a malfunction in the small pulmonary arteries. The small blood vessels in our body that lead ...

A recent publication in the International Journal of Cardiology, Pulmonary ... effective and life-changing treatments for patients with complex conditions like pulmonary hypertension.

Sotatercept improves exercise capacity and delays the time to clinical worsening in patients with World Health Organization (WHO) functional class II or III pulmonary arterial hypertension.

A recent publication in the International Journal of Cardiology, "Pulmonary ... effective and life-changing treatments for patients with complex conditions like pulmonary hypertension.